Chuck Royce's OPRX Position Overview
Chuck Royce (via Royce & Associates Lp) currently holds 888,030 shares of OptimizeRx Corporation (OPRX) worth $5.58 M, representing 0.06% of the portfolio. First purchased in 2020-Q2, this medium-term investment has been held for 16 quarters.
Based on 13F filings, Chuck Royce has maintained a strategic position in OPRX, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2024, adding 1.07 M shares. Largest reduction occurred in Q2 2025, reducing 203,660 shares.
Analysis based on 13F filings available since 2013 Q2
Chuck Royce's OptimizeRx Corporation (OPRX) Holding Value Over Time
Track share changes against reported price movement
Quarterly OptimizeRx Corporation (OPRX) Trades by Chuck Royce
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +206,000 | Add 30.20% | 888,030 | $6.28 |
| Q4 2025 | +4,700 | Add 0.69% | 682,030 | $12.26 |
| Q3 2025 | -113,310 | Reduce 14.33% | 677,330 | $20.50 |
| Q2 2025 | -203,660 | Reduce 20.48% | 790,640 | $13.50 |
| Q1 2025 | -75,260 | Reduce 7.04% | 994,300 | $8.66 |
| Q4 2024 | +1.07 M | New Buy | 1.07 M | $4.86 |
| Q3 2022 | -44,000 | Sold Out | 0 | $0.00 |
| Q1 2022 | +44,000 | New Buy | 44,000 | $37.70 |
| Q4 2021 | -11,450 | Sold Out | 0 | $0.00 |
| Q3 2021 | -13,750 | Reduce 54.56% | 11,450 | $85.59 |
| Q2 2021 | +800 | Add 3.28% | 25,200 | $61.90 |
| Q1 2021 | +1,500 | Add 6.55% | 24,400 | $48.77 |
| Q4 2020 | +2,900 | Add 14.50% | 22,900 | $31.18 |
| Q3 2020 | +5,100 | Add 34.23% | 20,000 | $20.85 |
| Q2 2020 | +14,900 | New Buy | 14,900 | $13.02 |
Chuck Royce's OptimizeRx Corporation Investment FAQs
Chuck Royce first purchased OptimizeRx Corporation (OPRX) in Q2 2020, acquiring 14,900 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Chuck Royce has held OptimizeRx Corporation (OPRX) for 16 quarters since Q2 2020.
Chuck Royce's largest addition to OptimizeRx Corporation (OPRX) was in Q4 2024, adding 1,069,560 shares worth $5.2 M.
According to the latest 13F filing for Q1 2026, Chuck Royce's firm, Royce & Associates Lp, owns 888,030 shares of OptimizeRx Corporation (OPRX), valued at approximately $5.58 M.
As of the Q1 2026 filing, OptimizeRx Corporation (OPRX) represents approximately 0.06% of Chuck Royce's publicly disclosed stock portfolio, making it one of their key holdings.
Chuck Royce's peak holding in OptimizeRx Corporation (OPRX) was 1,069,560 shares, as reported at the end of Q4 2024.